Author

A. Adair

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Microbiology· 1 Pathology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cancer & tumor microenvironment· 1 Assay:clinical cohort / trial· 1 Approach:experimental assay· 1 Organism:human· 1 Organism:plant (other)· 1 Research Focus:protein folding & dynamics· 1 Assay:protein structure· 1 Approach:statistical model· 1

Frequent Co-Authors

A. Christie· 1 shared A. Stockman· 1 shared A. W. Lo· 1 shared C. Hay· 1 shared D. J. Mole· 1 shared D. Worrall· 1 shared E. Harrison· 1 shared G. Weir· 1 shared

Activity by Year

2018-2020 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 36 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperPathology

A. Christie

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Nanobody generation and structural characterization of Plasmodium falciparum 6-cysteine protein Pf12p

M. H. Dietrich, L.-J. Chan, A. Adair, S. Keremane, P. Pymm, A. W. Lo, Y.-C. Cao, W.-H. Tham

The paper presents the first crystal structure of Pf12p, a 6-cysteine protein from Plasmodium falciparum, and describes nanobodies that target distinct epitopes on the protein.

bioRxiv · Dec 12, 2020Microbiology

Patterns of recurrence after curative-intent surgery for pancreas cancer reinforce the importance of locoregional control and adjuvant chemotherapy.

R. Munir, K. Soreide, R. Ravindran, J. J. Powell, E. Harrison, A. Adair, S. Wigmore, R. Parks, O. J. Garden, L. Kirkpatrick, L. R. Wall, A. Christie, I. Penman, N. McAvoy, V. Save, , D. J. Mole

This study examines recurrence patterns in pancreas cancer patients after surgery, finding that locoregional recurrence is common and linked to R+ resection and venous invasion, with adjuvant chemotherapy improving survival.

bioRxiv · Oct 18, 2018 · PreprintPathology